Article Details
Retrieved on: 2024-08-05 13:38:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Clinical-stage biotechnology company Destiny Pharma announced new data on its lead drug, exeporfinium chloride (XF-73), on Monday.
Article found on: www.sharecast.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here